Bolivia vs Oman: Hepatitis B surface antigen (HBsAg) prevalence
Bolivia
0.1%
in 2024
Oman
0.1%
in 2024
Bolivia rank
101st
Oman rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bolivia
- Oman
How they compare
Bolivia currently reports 0.1% against 0.1% in Oman, a difference of 0.0%.
Across all 10 years both countries report, Oman has been ahead every year.
Bolivia ranks 101st and Oman ranks 101st of 194 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Oman |
| 2020s | 0.1% | 0.1% | 0.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bolivia or Oman?
- Bolivia, at 0.1% against 0.1% in Oman as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bolivia and Oman?
- 0.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Oman?
- 10 years are reported by both, from 2015 to 2024.
- How do Bolivia and Oman rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bolivia ranks 101st and Oman ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.